Journal of Thoracic Oncology最新文献

筛选
英文 中文
Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening Trial 在约克郡肺筛查试验中肺癌筛查资格标准和肺癌检测的前瞻性评价。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2024.12.016
Rhian Gabe PhD , Philip A.J. Crosbie PhD , Daniel Vulkan MSc , Hannah Bailey M.B.B.S. , David R. Baldwin MD , Claire Bradley MBBCh , Richard Booton PhD , Michael J. Darby FRCR , Claire Eckert PhD , Neil Hancock BEng , Sebastian Hinde PhD , Sam M. Janes PhD , Martyn P.T. Kennedy MBChB , Catriona Marshall PhD , Henrik Moller Dr.Med. , Rachael L. Murray PhD , Richard D. Neal PhD , Samantha L. Quaife PhD , Suzanne Rogerson RN , Bethany Shinkins DPhil , Matthew E.J. Callister PhD
{"title":"Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening Trial","authors":"Rhian Gabe PhD ,&nbsp;Philip A.J. Crosbie PhD ,&nbsp;Daniel Vulkan MSc ,&nbsp;Hannah Bailey M.B.B.S. ,&nbsp;David R. Baldwin MD ,&nbsp;Claire Bradley MBBCh ,&nbsp;Richard Booton PhD ,&nbsp;Michael J. Darby FRCR ,&nbsp;Claire Eckert PhD ,&nbsp;Neil Hancock BEng ,&nbsp;Sebastian Hinde PhD ,&nbsp;Sam M. Janes PhD ,&nbsp;Martyn P.T. Kennedy MBChB ,&nbsp;Catriona Marshall PhD ,&nbsp;Henrik Moller Dr.Med. ,&nbsp;Rachael L. Murray PhD ,&nbsp;Richard D. Neal PhD ,&nbsp;Samantha L. Quaife PhD ,&nbsp;Suzanne Rogerson RN ,&nbsp;Bethany Shinkins DPhil ,&nbsp;Matthew E.J. Callister PhD","doi":"10.1016/j.jtho.2024.12.016","DOIUrl":"10.1016/j.jtho.2024.12.016","url":null,"abstract":"<div><h3>Introduction</h3><div>Low-dose computed tomography screening for lung cancer reduces lung cancer mortality, but there is a lack of international consensus regarding the optimal eligibility criteria for screening. The Yorkshire Lung Screening Trial was designed to evaluate lung cancer screening (LCS) implementation, and a primary objective was prospective evaluation of three predefined eligibility criteria.</div></div><div><h3>Methods</h3><div>Individuals who had ever smoked, aged 55 to 80 years, who responded to written invitation, underwent telephone risk assessment and if eligible by at least one criterion (PLCO<sub>M2012</sub> ≥ 1.51%, LLP<sub>v2</sub> ≥ 5%, USPSTF<sub>2013</sub>) were offered biennial low-dose computed tomography screening.</div></div><div><h3>Results</h3><div>Of 44,957 individuals invited, 22,814 responded and underwent eligibility assessment, of whom a total of 7826 were eligible according to any of the three LCS criteria. Comparing PLCO<sub>M2012</sub> ≥ 1.51%, LLP<sub>v2</sub> ≥ 5%, and USPSTF<sub>2013</sub>, the proportions of responders eligible for screening were 28.0%, 20.5%, and 18.9%, respectively (<em>p</em> &lt; 0.0001 for each comparison), and the proportion of all cancers detected 91.1%, 77.0%, and 62.8%, respectively (<em>p</em> ≤ 0.0002 for each comparison). When risk thresholds were selected to result in equivalent numbers of people eligible for screening, cancer detection proportions were higher for PLCO<sub>M2012</sub> (74.5%) and LLP<sub>v2</sub> (71.3%) than USPSTF<sub>2013</sub> (62.8%) (<em>p</em> = 0.0002 and <em>p</em> = 0.032, respectively), but there was no significant difference between the two risk models. Reducing the LLPv2 risk threshold from 5% to 2.5% (as currently used in the English LCS program) and reducing the pack-year requirement for the USPSTF<sub>2021</sub> versus the USPSTF<sub>2013</sub> criteria increased the numbers eligible for screening, but subsequent cancer yield was not measured in this study.</div></div><div><h3>Conclusion</h3><div>The PLCO<sub>M2012</sub> ≥ 1.51% criteria identified more people eligible for screening in Yorkshire Lung Screening Trial and resulted in more screen-detected lung cancers than LLP<sub>v2</sub> ≥ 5% or USPSTF<sub>2013</sub>. When compared in equivalent populations, there was no significant difference between risk models in terms of lung cancer detection and each appeared more efficient at screening population selection than USPSTF<sub>2013</sub>.</div></div>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages 425-436"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns Regarding Linear Assumptions in Principal Component Analysis: Advocating for Nonlinear and Nonparametric Approaches in Pulmonary Carcinoid Research 对主成分分析中线性假设的关注:提倡在类肺癌研究中采用非线性和非参数方法
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2024.12.024
Yoshiyasu Takefuji PhD
{"title":"Concerns Regarding Linear Assumptions in Principal Component Analysis: Advocating for Nonlinear and Nonparametric Approaches in Pulmonary Carcinoid Research","authors":"Yoshiyasu Takefuji PhD","doi":"10.1016/j.jtho.2024.12.024","DOIUrl":"10.1016/j.jtho.2024.12.024","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages e54-e55"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Response to the Letter to the Editor: “Clinical Value of Incidental Lung Nodule Detection” 对《偶发肺结节检测的临床价值》致编辑信的回复
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.01.005
Stephanie Tuminello PhD, Matthew Untalan MS, Raja Flores MD, Emanuela Taioli MD, PhD
{"title":"A Response to the Letter to the Editor: “Clinical Value of Incidental Lung Nodule Detection”","authors":"Stephanie Tuminello PhD,&nbsp;Matthew Untalan MS,&nbsp;Raja Flores MD,&nbsp;Emanuela Taioli MD, PhD","doi":"10.1016/j.jtho.2025.01.005","DOIUrl":"10.1016/j.jtho.2025.01.005","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page e58"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.15 Transcriptional Changes Associated with Tolerance to EGFR Tyrosine Kinase Inhibitors in Mutant EGFR Lung Cancer PDX Models 突变型EGFR肺癌PDX模型中与EGFR酪氨酸激酶抑制剂耐受性相关的转录变化
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.03.022
Nhu-An Pham , Quan Li , Arundhathi Arivajiagane , Katrina Hueniken , Yoshiaki Inoue , Masashi Mikubo , Ming Li , Ming-Sound Tsao
{"title":"PP01.15 Transcriptional Changes Associated with Tolerance to EGFR Tyrosine Kinase Inhibitors in Mutant EGFR Lung Cancer PDX Models","authors":"Nhu-An Pham ,&nbsp;Quan Li ,&nbsp;Arundhathi Arivajiagane ,&nbsp;Katrina Hueniken ,&nbsp;Yoshiaki Inoue ,&nbsp;Masashi Mikubo ,&nbsp;Ming Li ,&nbsp;Ming-Sound Tsao","doi":"10.1016/j.jtho.2025.03.022","DOIUrl":"10.1016/j.jtho.2025.03.022","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages S8-S9"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.09 Integrin-Linked Kinase Drives Drug-Tolerant Persister Cell Survival and EMT in Response to EGFR Inhibition in Lung Adenocarcinoma 整合素连接激酶驱动耐药持久性细胞存活和EMT响应EGFR抑制肺腺癌
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.03.017
Rocky Shi , Dylan A. Farnsworth , Christopher A. Febres-Aldana , Justine LM. Chow , Ravinder Sheena , Tejveer Atwal , Juan Luis Gomez Marti , Kiersten N. Thomas , Che-Min Lee , Shannon J. Awrey , Paul C. McDonald , Romel Somwar , Shoukat Dedhar , Marc Ladanyi , Kevin L. Bennewith , William W. Lockwood
{"title":"PP01.09 Integrin-Linked Kinase Drives Drug-Tolerant Persister Cell Survival and EMT in Response to EGFR Inhibition in Lung Adenocarcinoma","authors":"Rocky Shi ,&nbsp;Dylan A. Farnsworth ,&nbsp;Christopher A. Febres-Aldana ,&nbsp;Justine LM. Chow ,&nbsp;Ravinder Sheena ,&nbsp;Tejveer Atwal ,&nbsp;Juan Luis Gomez Marti ,&nbsp;Kiersten N. Thomas ,&nbsp;Che-Min Lee ,&nbsp;Shannon J. Awrey ,&nbsp;Paul C. McDonald ,&nbsp;Romel Somwar ,&nbsp;Shoukat Dedhar ,&nbsp;Marc Ladanyi ,&nbsp;Kevin L. Bennewith ,&nbsp;William W. Lockwood","doi":"10.1016/j.jtho.2025.03.017","DOIUrl":"10.1016/j.jtho.2025.03.017","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page S6"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.25 Exploring the Impact of Socioeconomic and Geographic Factors on Immunotherapy Discontinuation and Success in Northern Ontario: A Retrospective, Single-Center Cohort Study 探索社会经济和地理因素对安大略省北部免疫治疗中断和成功的影响:一项回顾性、单中心队列研究
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.03.028
Alesha Bishop , Olexiy Aseyev
{"title":"PP01.25 Exploring the Impact of Socioeconomic and Geographic Factors on Immunotherapy Discontinuation and Success in Northern Ontario: A Retrospective, Single-Center Cohort Study","authors":"Alesha Bishop ,&nbsp;Olexiy Aseyev","doi":"10.1016/j.jtho.2025.03.028","DOIUrl":"10.1016/j.jtho.2025.03.028","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages S10-S11"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143758991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.22 Targeting GTP-Bound KRAS and mTOR in Lung Adenocarcinoma and Squamous Cell Carcinoma Harboring KRAS G12C PP01.22靶向gtp结合KRAS和mTOR在肺腺癌和鳞状细胞癌中携带KRAS G12C
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.03.026
Masaoki Ito , Yoshihiro Miyata , Kenichi Suda , Yasuhiro Tsutani , Morihito Okada
{"title":"PP01.22 Targeting GTP-Bound KRAS and mTOR in Lung Adenocarcinoma and Squamous Cell Carcinoma Harboring KRAS G12C","authors":"Masaoki Ito ,&nbsp;Yoshihiro Miyata ,&nbsp;Kenichi Suda ,&nbsp;Yasuhiro Tsutani ,&nbsp;Morihito Okada","doi":"10.1016/j.jtho.2025.03.026","DOIUrl":"10.1016/j.jtho.2025.03.026","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page S10"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.17 Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as Independent Prognostic Markers in EGFR- Tested Advanced Non-small Cell Lung Cancer PP01.17 中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)作为表皮生长因子受体(EGFR)检测的晚期非小细胞肺癌的独立预后指标
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.03.024
Kijjakom Thanasombunsukh , Sukrit Treewattanawong
{"title":"PP01.17 Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as Independent Prognostic Markers in EGFR- Tested Advanced Non-small Cell Lung Cancer","authors":"Kijjakom Thanasombunsukh ,&nbsp;Sukrit Treewattanawong","doi":"10.1016/j.jtho.2025.03.024","DOIUrl":"10.1016/j.jtho.2025.03.024","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page S9"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tobacco News Update–From the IASLC Tobacco Control Committee 烟草新闻更新-来自IASLC烟草控制委员会
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2025.02.015
{"title":"Tobacco News Update–From the IASLC Tobacco Control Committee","authors":"","doi":"10.1016/j.jtho.2025.02.015","DOIUrl":"10.1016/j.jtho.2025.02.015","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages 408-410"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC” 对“平衡不再是涉及精确肿瘤治疗方法的非小细胞肺癌3期随机对照试验伦理评价的主要考虑因素”的回应
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-04-01 DOI: 10.1016/j.jtho.2024.12.017
Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth, Wendy Lipworth M.B.B.S., PhD, Sue-Anne McLachlan M.B.B.S., MSc, FRACP, Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD, Tom John M.B.B.S., PhD, FRACP, Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA
{"title":"A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”","authors":"Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth,&nbsp;Wendy Lipworth M.B.B.S., PhD,&nbsp;Sue-Anne McLachlan M.B.B.S., MSc, FRACP,&nbsp;Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD,&nbsp;Tom John M.B.B.S., PhD, FRACP,&nbsp;Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA","doi":"10.1016/j.jtho.2024.12.017","DOIUrl":"10.1016/j.jtho.2024.12.017","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages e51-e52"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信